Evidence map›Paper›PMID 38523523›Full record

ReviewRecent patents on nanotechnology2025

A New Approach in the Early Electrochemical Diagnosis of Hepatitis B Virus Infection using Carbon-based Nanomaterials.

Navid Omidifar, Reza Masoumzadeh, Seyyed Amirreza Saghi, Ali Nikmanesh, Mansoureh Shokripour, Seyyed Mojtaba Mousavi, Yousef Nikmanesh, Ahmad Gholami

Abstract readReview
PubMed Publisher
In one paragraph

Review in Recent patents on nanotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Navid OmidifarBiotechnology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Reza MasoumzadehDepartment of Pathology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.
Seyyed Amirreza SaghiDepartment of Medical, Larestan University of Medical Sciences, Larestan, Iran.
Ali NikmaneshDepartment of Pharmaceutical Biotechnology, School of Pharmacy, Biotechnology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Mansoureh ShokripourDepartment of Pathology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.
Seyyed Mojtaba MousaviDepartment of Chemical Engineering, National Taiwan University of Science and Technology, Taipei, 10607, Taiwan.
Yousef NikmaneshGastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Ahmad GholamiBiotechnology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Funding

Shiraz University of Medical Sciences 25696
6 · The paper itself

Abstract

The importance of early diagnosis of hepatitis B virus infection to treat and follow up this disease has led to many advances in diagnostic techniques and materials. Conventional diagnostic tests are not very useful, especially in the early stages of infection; it is therefore suggested that nanomaterials can enhance them by changing and strengthening their performance for a more accurate and rapid diagnosis. Electrochemical immunosensors with unique features such as miniaturization, low cost, specificity and simplicity have become a suitable and vital tool in the rapid diagnosis of hepatitis B since the patent. Different strategies have been presented, such as graphene oxide and gold nanorods (GO-GNRs), graphene oxide (GO), copper metal-organic framework/ electrochemically reduced graphene oxide (Cu-MOF/ErGO) composite, Label-free graphene oxide/ Fe

Indexed as

Biosensing TechniquesElectrochemical TechniquesHepatitis BHepatitis B virusNanostructuresNanotubes, CarbonEarly DiagnosisGoldGraphiteHumansImmunoassayPatents as TopicGoldgraphene oxideGraphiteNanotubes, Carboncarbon nanotubesearly diagnosiselectrochemical immunosensors.graphenequantum dotViral hepatitis

Identifiers

PMID38523523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.